Purified milk sphingomyelin (SM) was obtained from lipid concentrated butter serum 16 (LC-BS) by successive separations involving solvent fractionation, selective 17 saponification, and silicic acid column chromatography. The SM obtained was given to 18 obese/diabetic KK-A y mice and wild-type C57BL/6J mice. SM supplementation 19 significantly increased fecal lipids paralleled with a decrease in non-HDL cholesterol 20 levels in the serum and neutral lipids and in cholesterol levels in the livers of KK-A y 21 mice. The reduction of liver lipid levels also resulted in a decrease in the total fatty acid 22 content of the KK-A y mice livers, while n-3 fatty acids derived from the conversion of 23 α-linolenic acid (18:3n-3) increased due to SM supplementation. In contrast to the 24 KK-A y mice, little change in the serum and liver lipids was observed in wild-type 25 C57BL/6J mice. The present study suggests that SM may be effective only in subjects 26 with metabolic disorders. 27 28 30 fat droplets. It prevents the globules from coalescence, stabilizes them in the milk serum, 31 and protects them from enzymatic attack by lipases. 1 MFGM is a mixture of bioactive 32 proteins and polar lipids. Mechanical treatments induce the release of MFGM from fat 33 globules into the corresponding serum phase (i.e., buttermilk and butter serum). Butter 34 serum is produced from butter to anhydrous milk fat production and is rich in proteins 35 and phospho-and sphingolipids from MFGM. The major phospholipids (PL) are 36 2 phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylserine, and 37 phosphatidylinositol, while the major sphingolipids (SL) are glucosylceramide, 38 lactosylceramide, and sphingomyelin (SM). 39 Milk nutrients have attracted attention as functional foods and nutraceuticals with 40 potentially important cardioprotective properties. Recent studies showed that increased 41 consumption of milk and dairy products is associated with a reduced incidence of 42 obesity, insulin resistance, dyslipidemia, and type 2 diabetes, which are cardiovascular 43 risk factors. 2 Among the milk component, polar lipids rich in butter serum have been 44 considered active components in the improvement of lipid metabolism. The 45 hypolipidemic and/or hypocholesterolemic activity of milk PL and SL have been found 46 in animal models. 3-5 Wat et al. 5 reported a significant decrease in the liver weight, total 47 liver lipid, liver triacylglycerol (TAG), and total cholesterol and serum lipids of mice 48 fed a high-fat diet with a PL-rich dairy milk extract. Milk PL supplementation could 49 also significantly decrease the total liver cholesterol and TAG levels of mice (C57BL/6) 50 fed a high-fat diet. 4 On the other hand, we have found a significant decrease in the 51 plasma cholesterol, hepatic total cholesterol and TAG levels of obese/diabetic mice 52 (KK-A y ) by the supplementation of lipid concentrated butter serum (LC-BS). 53 Furthermore, when ceramide, SM, PE, and PC rich fractions from LC-BS was given to 54 the KK-Ay mice, significant decrease in plasma cholesterol and hepatic lipid levels was 55 found in the animals fed ceramide fraction. 5 The decrease was also found in the mice 56 fed SM fraction. On the other hand, there was little effect of PE and PC fractions on the 57 lipid levels. This result suggested that the effect of LC-BS is mainly due to SL, the main 58 components of LC-BS. 5 However, purity of ceramide and SM fractions used in the 59 study was 70.7 and 49.9% respectively. A human study has also demonstrated the 60 possible effect of the intake of milk polar lipids on cholesterol absorption from the 61 intestine and/or hepatic metabolism. 6 62
Introduction 29
The milk fat globule membrane (MFGM) is a biological membrane that surrounds milk dehydrogenase and Fe(CN) 6 3-. After feeding with the experimental diets for four weeks, 181 the mice were sacrificed under diethyl ether anesthesia. Blood samples were taken from 182 the caudal vena cava of the mice and each tissue was immediately excised and weighed. 183 The livers were immediately stored in RNA later™ (Sigma Chemical Co., St. Louis, 184 MO) for quantitative real time PCR analysis. 185 186 Blood lipid analysis 187 The blood serum analysis of the KK-A y mice was performed by the Analytical Center of 188 Hakodate Medical Association (Hakodate, Japan). The analysis included the 189 measurement of the following parameters: total cholesterol, neutral lipids (NL), PL, 190 Non-HDL cholesterol, LDL cholesterol, and HDL cholesterol. Blood serum from 191 C57BL/6J mice was extracted with chloroform/methanol (2:1, v/v) according to the 192 method by Folch et al. (1957) . The total lipids (TL) extracted were weighed and the 193 serum TAG and cholesterol content were enzymatically measured using commercial kits 194 (Cholesterol E-test and Triglyceride E-test, Wako Pure Chemical Industries Ltd., Osaka, 195 Japan). 196 Some period of fasting is required before glucose tolerance test and needed to obtain 197 stable baseline measurements of blood lipid parameters; however, several recent studies 198 have demonstrated the adverse effect of fasting in rodents. 10, 11 During the fasting, 199 especially overnight fasting, they consume much calories and prolonged fasting inhibits 200 insulin-stimulated glucose uptake in humans, but increases the insulin sensitivity in 201 mice. In the present study, we used non-fasting mice for the analysis of blood glucose 202 and serum lipid parameters. 203 204 Liver Lipid Analysis 205 TL was extracted from the liver (ca. 200 mg) with chloroform/methanol (2:1, v/v). 9 The 206 TL (ca. 20 mg) was further separated on a Sep-Pak Silica cartridge (Waters Japan, 207 Tokyo, Japan) by elution with chloroform (50 mL) and methanol (50 mL). The NL and 208 PL fractions were eluted with chloroform and methanol, respectively. Both lipid 209 contents (mg/g liver) in the liver were calculated from the TL level per liver weight. The 210 TAG and cholesterol content in the TL were enzymatically measured using commercial 211 kits as described above. 212 The fatty acid methyl esters from the liver TL were prepared using the method of 213 Prevot and Mordret. 12 Briefly, 1 mL of n-hexane and 0.2 mL of 2 N NaOH in methanol 214 were added to an aliquot of total lipid (ca. 10 mg), vortexed and incubated at 50°C for solution and vortexed. The mixture was separated by centrifugation at 1000 g for 5 min.
217
The upper hexane layer containing fatty acid methyl esters was recovered and subjected 218 to GC. The GC was performed as described above. Each fatty acid level of the liver 219 tissue (1 g) was calculated by comparing the peak ratio to that of the internal standard 220 (17:0) and the total lipid content. Total RNA was extracted from the livers of mice using RNeasy Lipid Tissue Mini Kits 241 (Qiagen, Tokyo, Japan) according to the manufacturer's protocol. The cDNA was then 242 synthesized from total RNA using High-Capacity cDNA Reverse Transcription Kits 243 (Applied Biosystems Japan Ltd., Tokyo, Japan). Quantitative real-time PCR analyses of 244 individual cDNA were performed with ABI Prism 7500 (Applied Biosystems Japan Ltd.,
245
Tokyo, Japan) using TaqMan Gene Expression Assays (Applied Biosystems Japan Ltd.,
246
Tokyo, Japan). The mRNA analyses were performed on genes associated with lipid 247 metabolism, which included sterol regulatory element-binding protein 2 (SREBP-2), analysis by GC showed that the major fatty acids of SM were long chain saturated fatty 278 acids such as 22:0, 23:0, and 24:0. The GC analysis also showed the major fatty acids of 279 lard (18:1n-9, 16:0, and 18:0), soybean oil (18:2n-6 and 18:1n-9), linseed oil (18:3n-3, 280 18:1n-9, and 18:2n-6), and fish oil (22:6n-3 and 20:5n-3). The fatty acid profile of the 281 lipids extracted from each diet is shown in 286 There were significant differences in several parameters, namely, water intake and liver 287 weight for KK-A y mice, and food intake, water intake, liver weight, kidney weight, and small intestine weight for C57BL/6J mice (Table 3) . On the other hand, no significant 289 difference was found in body weight, total white adipose tissue (WAT) weight, and 290 blood glucose level in both animal models. There was also no significant difference in 291 the blood glucose levels at 0, 7, 14, 21, and 28 days after feeding.
292
On the other hand, serum total cholesterol, PL, non-HDL cholesterol, and LDL 293 cholesterol levels were affected by the dietary lipids in KK-A y mice, although little 294 effect was found in the levels of NL and HDL cholesterol ( Fig. 1 ). SM supplementation 295 decreased non-HDL cholesterol levels in soybean oil-and linseed oil-fed mice ( Fig. 1 296 D). The same tendency was also observed in total cholesterol ( Fig. 1 A) and 297 phospholipids ( Fig. 1 C) . When the comparison was done between the two groups fed 298 the same dietary lipids with or without SM, the significant decrease in the LDL 299 cholesterol levels was found by SM supplementation in soybean oil-and linseed oil-fed 300 mice ( Fig. 1 E) . A similar dietary effect was found in the liver lipid content (Figure 2 ).
301
The reducing effect of SM supplementation was found on the TL ( Fecal lipids. 312 The fecal concentrations of TL, cholesterol, and PL were also affected by dietary lipids 313 ( Fig. 5 and 6 ). In the KK-A y mice, the fecal TL content was the lowest in the linseed 314 oil-fed group; however, the level (88.7+41.2 mg/g feces) significantly increased to 315 221.7±27.6 mg/g feces following SM supplementation ( Fig. 5 A) . The excretion of total 316 lipids in the feces was promoted by SM supplementation in the lard-and soybean-fed 317 groups. Fecal cholesterol levels were also increased by SM supplementation and 318 significant difference between with or without SM diets were found in the lard-and 319 linseed oil-fed groups (Fig. 5 B) . Bile acid was also significantly increased by SM 320 supplementation in lard-fed group, while there was no significant effect of SM 321 supplementation in other two groups ( Fig. 5 C) . The increase in fecal TL was also found 322 in C57BL/6J mice ( Fig. 6 ). Although statistical analyses could not be performed 323 because the experimental groups with C57BL/6J mice were housed in the same cage, the result in Fig. 6 strongly suggests the greater excretion of TL in the feces following 325 SM supplementation in C57BL/6J mice. To confirm the promotion of TL secretion into 326 the feces in C57BL/6J mice by SM supplementation, separate animal experiments have 327 been performed using dietary lipids containing 230 g/kg lard and 70 g/kg soybean oil or 328 60 g/kg soybean oil + 10 g/kg SM. When both diets (Table 1) were given to wild-type 329 C57BL/6J mice (male, four weeks old, n=7) for 29 days, a significant increase in the TL 330 in the feces following SM supplementation was observed 15 and 29 days after feeding 331 ( Fig. 7) .
333
Fatty acid levels of liver lipids and gene expression 334 Lard diets contained higher levels of saturated and monounsaturated fatty acids, such as 335 16:0 and 18:1n-9, than the other dietary groups (Table 2) . Thus, high levels of 16:0 and 336 18:1n-9 were found in the liver lipids of lard-fed KK-A y mice (Table 4 ). The 337 characteristic fatty acid compositions of the soybean oil and linseed oil groups were soybean oil-and linseed oil-fed groups. The change in the ratio of monoenoic fatty 361 acid/saturated fatty acid was consistent with the dietary up-and down-regulation of 362 SCD1 mRNA presented in Fig. 9 . LA and ALA are converted to ARA and DHA, 363 respectively, through a series of desaturation and chain elongation processes including 364 Elov2, Elov5, Fads1, and Fads2. The different diet feeding resulted in the significant 365 changes in the expression of Elov2, Elov5, and Fads2 ( Fig. 9 ), while no significant 366 difference was found in the expression of Fads1.
367
On the other hand, no decrease in the liver total fatty acids was observed in 368 C57BL/6J mice following SM supplementation ( Table 5 ). The fatty acid composition of 369 the liver lipids was well reflected by the dietary lipids to show the high level of ALA 370 and DHA in the linseed oil-and fish oil-fed group, respectively; however, no specific 371 effect of SM supplementation was found on the fatty acid composition including 372 18:1n-9/18:0 and 16:1n-7/16:0 ratio. In addition, there was no significant difference in 373 gene expression related to lipid metabolism with or without SM supplementation. Western diet of ~200-400 mg/day. 16, 17 Studies have examined the effects of dietary SM 380 and have found reductions of the liver and plasma lipid levels. 18 In the present study, we 381 also found that dietary SM could reduce the liver and plasma lipid levels of 382 obese/diabetic KK-A y mice (Fig. 1, 2, and obese Zucker rats. 22 The present study also confirmed the reduction of serum and liver 400 lipid levels in obese/diabetic mice through the promotion of intestinal lipid secretion by 401 SM. Dietary SM also promoted fecal lipids in wild-type C57BL/6J mice ( Fig. 6 and 7) ; absorbed by the intestine is metabolized to fatty acids and a small part is resynthesized 482 to complex sphingolipids. Therefore, more effort will be needed to investigate the direct 483 action of SM metabolites, such as sphingoid bases, in biological systems.
484
In conclusion, our present study showed the inhibitory effect of SM on intestinal were not affected by the interaction of dietary lipids and SM feeding. Therefore, the 
